Advertisement

Topics

Paul Capital Partners Company Profile

04:44 EST 25th November 2017 | BioPortfolio

Founded in 1991, Paul Capital Partners is not only an established member of the global private equity community, but is recognized as an industry innovator. We are a partner of choice, offering fair value, predictable liquidity, and well-tailored transactions, through our three distinct areas of investment: Healthcare Royalty and Revenue Interests, Private Equity Secondaries and Top Tier Venture Funds.

Location

50 California StreetSuite 3000
San Francisco
California
94111
United States of America

Contact

Phone: (415) 283-4300
Fax: (415) 283-4301


News Articles [1422 Associated News Articles listed on BioPortfolio]

Paul Capital Partners: Financing and Risk Sharing

In this episode of PharmaTelevision News Review, Fintan Walton talks with Ken MacLeod, Partner at Paul Capital Partners. Filmed at BioTrinity 2010 in Newbury, UK.

Paul Capital Partners: Growth Capital Providers for the Biotech Industry

In this interview, filmed during the recent BIO conference in San Diego, Fintan Walton speaks with Ken Macleod, partner in the well-known Paul Capital Partners, located in London. He tells how the com...

Israeli genetic data co Genoox raises $6m

The round was led by led by Inimiti Capital Partners and Glilot Capital Partners.

MorphoSys-Aktie: Short-Attacke! Leerverkäufer GSA Capital Partners baut Shortposition auf - Aktiennews

Martinsried - Leerverkäufer GSA Capital Partners LLP geht Netto-Leerverkaufsposition in MorphoSys-Aktien ein: Die Leerverkäufer des Hedgefonds GSA Capital Partners LLP attackieren die Aktien des Bi....

M&As this week: Court Square Capital Partners, Quotient Sciences Limited, Jinzi Ham

Court Square Capital Partners has acquired a majority stake in clinical research organisation Celerion Holdings from MTS Health Investors. Both Court...Read More... The post M&As this week: Court...

Apposite Capital: Weathering the storm with a hands on approach to investing.

In this episode of PharmaTelevision News Review filmed at BioTrinity 2012, Paul Larsmon talks to Chris Hollowood, Partner, Apposite Capital

Brandon Capital Partners: Dr David Fisher discusses their role in Medical Research Commercialization Fund

In this episode of PharmaTelevision News Review, Fintan Walton talks to Dr David Fisher, Venture Partner of Brandon Capital Partners

Apellis raises $60mm in Series E round

Apellis Pharmaceuticals Inc. (immunotherapies for autoimmune and inflammatory diseases) raised $60mm through its Series E round. Sectoral Asset Management led and was joined by new investors Sofinnova...

Drugs and Medications [78 Associated Drugs and Medications listed on BioPortfolio]

Capmist [Capital Pharmaceutical]

CAPMIST DM TABLETS

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]

DAY CREAM MATTIFYING HYDRATOR

3m skin and nasal antiseptic [3M Company ]

3M™ Skin and Nasal Antiseptic(Povidone-Iodine Solution 5% w/w (0.5% available iodine) USP)

3m nexcare cold sore treatment [3M Company ]

Nexcare™ Cold Sore Treatment

PubMed Articles [383 Associated PubMed Articles listed on BioPortfolio]

Wildlife: topical issues, recent cases.

This focus article was prepared by Paul Duff, Paul Holmes and Alex Barlow of the APHA Wildlife Expert Group.

A Tale of Two Towns: A Comparative Study Exploring the Possibilities and Pitfalls of Social Capital among People Seeking Recovery from Substance Misuse.

Social capital has become an influential concept in debating and understanding the modern world. Within the drug and alcohol sector, the concept of 'recovery capital' has gained traction with research...

Perceptions of community, social capital, and how they affect self-reported health: a multilevel analysis.

The link between social capital and self-reported health has been widely explored. On the other hand, we know less about the relationship between social capital, community socioeconomic characteristic...

Recovery capital pathways: Modelling the components of recovery wellbeing.

In recent years, there has been recognition that recovery is a journey that involves the growth of recovery capital. Thus, recovery capital has become a commonly used term in addiction treatment and r...

The dark side of social capital: A systematic review of the negative health effects of social capital.

There is a growing literature demonstrating the health benefits of social capital (defined as the resources accessed through social connections). However, social capital is also acknowledged to be a "...

Clinical Trials [298 Associated Clinical Trials listed on BioPortfolio]

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

"Gait and Balance in Patients With SCFE"

Slipped Capital Femoral Epiphysis (SCFE) treated with one screw in situ fixation results in an altered gait. It is thought that the protraction of the pelvis at the affected side, seen in ...

Companies [1897 Associated Companies listed on BioPortfolio]

Paul Capital Healthcare

Through its funds, Paul Capital Healthcare is one of the largest dedicated healthcare investors globally, with more than $1.6 billion in equity capital commitments and debt facilities under management...

Advantage Capital Agribusiness Partners, LP

Advantage Capital Agribusiness Partners, LP (ACAP) is a $154.5-million fund that is licensed as a Rural Business Investment Company (RBIC) by the U.S. Department of Agriculture (U...

Paul Capital Partners

Founded in 1991, Paul Capital Partners is not only an established member of the global private equity community, but is recognized as an industry innovator. We are a partner of choice, offering fair v...

PBM Capital Group, LLC.

PBM Capital Group, LLC. is a private investment firm primarily focused on healthcare-related investments. Led by Paul Manning, a successful entrepreneur, PBM Capital partners w...

Oak Hill Capital Partners

Oak Hill Capital Partners is a private equity firm with more than $8.2 billion of committed capital from leading entrepreneurs, endowments, foundations, corporations, pension fund...

More Information about "Paul Capital Partners" on BioPortfolio

We have published hundreds of Paul Capital Partners news stories on BioPortfolio along with dozens of Paul Capital Partners Clinical Trials and PubMed Articles about Paul Capital Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Paul Capital Partners Companies in our database. You can also find out about relevant Paul Capital Partners Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record